149 related articles for article (PubMed ID: 36695734)
41. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.
Desponts C; Ding S
Methods Mol Biol; 2010; 636():207-18. PubMed ID: 20336525
[TBL] [Abstract][Full Text] [Related]
42. Tbx3 improves the germ-line competency of induced pluripotent stem cells.
Han J; Yuan P; Yang H; Zhang J; Soh BS; Li P; Lim SL; Cao S; Tay J; Orlov YL; Lufkin T; Ng HH; Tam WL; Lim B
Nature; 2010 Feb; 463(7284):1096-100. PubMed ID: 20139965
[TBL] [Abstract][Full Text] [Related]
43. Viable mice produced from three-factor induced pluripotent stem (iPS) cells through tetraploid complementation.
Kang L; Wu T; Tao Y; Yuan Y; He J; Zhang Y; Luo T; Kou Z; Gao S
Cell Res; 2011 Mar; 21(3):546-9. PubMed ID: 21119684
[No Abstract] [Full Text] [Related]
44. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
45. SCNT versus iPSCs: proteins and small molecules in reprogramming.
Han F; Li X; Song D; Jiang S; Xu Q; Zhang Y
Int J Dev Biol; 2015; 59(4-6):179-86. PubMed ID: 26505250
[TBL] [Abstract][Full Text] [Related]
46. Intermediate Standstill Clones Trapped in the Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells.
Zhang L; Wang Y; Zhang Y; Wang L; Huang H
Cell Reprogram; 2020 Apr; 22(2):99-105. PubMed ID: 32182120
[TBL] [Abstract][Full Text] [Related]
47. A site-specific genetic modification for induction of pluripotency and subsequent isolation of derived lung alveolar epithelial type II cells.
Yan Q; Quan Y; Sun H; Peng X; Zou Z; Alcorn JL; Wetsel RA; Wang D
Stem Cells; 2014 Feb; 32(2):402-13. PubMed ID: 24123810
[TBL] [Abstract][Full Text] [Related]
48. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.
Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K
Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261
[TBL] [Abstract][Full Text] [Related]
49. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
Greder LV; Post J; Dutton JR
Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
[TBL] [Abstract][Full Text] [Related]
50. Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.
Phang RZ; Tay FC; Goh SL; Lau CH; Zhu H; Tan WK; Liang Q; Chen C; Du S; Li Z; Tay JC; Wu C; Zeng J; Fan W; Toh HC; Wang S
Stem Cells Transl Med; 2013 Dec; 2(12):935-45. PubMed ID: 24167318
[TBL] [Abstract][Full Text] [Related]
51. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
[TBL] [Abstract][Full Text] [Related]
52. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
53. H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells.
Kunitomi A; Yuasa S; Sugiyama F; Saito Y; Seki T; Kusumoto D; Kashimura S; Takei M; Tohyama S; Hashimoto H; Egashira T; Tanimoto Y; Mizuno S; Tanaka S; Okuno H; Yamazawa K; Watanabe H; Oda M; Kaneda R; Matsuzaki Y; Nagai T; Okano H; Yagami KI; Tanaka M; Fukuda K
Stem Cell Reports; 2016 Jun; 6(6):825-833. PubMed ID: 27237376
[TBL] [Abstract][Full Text] [Related]
54. Generation of pig iPS cells: a model for cell therapy.
Montserrat N; Bahima EG; Batlle L; Häfner S; Rodrigues AM; González F; Izpisúa Belmonte JC
J Cardiovasc Transl Res; 2011 Apr; 4(2):121-30. PubMed ID: 21088946
[TBL] [Abstract][Full Text] [Related]
55. Understanding impediments to cellular conversion to pluripotency by assessing the earliest events in ectopic transcription factor binding to the genome.
Soufi A; Zaret KS
Cell Cycle; 2013 May; 12(10):1487-91. PubMed ID: 23603987
[TBL] [Abstract][Full Text] [Related]
56. Heterochromatin loosening by the Oct4 linker region facilitates Klf4 binding and iPSC reprogramming.
Chen K; Long Q; Xing G; Wang T; Wu Y; Li L; Qi J; Zhou Y; Ma B; Schöler HR; Nie J; Pei D; Liu X
EMBO J; 2020 Jan; 39(1):e99165. PubMed ID: 31571238
[TBL] [Abstract][Full Text] [Related]
57. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
58. Cooperative Binding of Transcription Factors Orchestrates Reprogramming.
Chronis C; Fiziev P; Papp B; Butz S; Bonora G; Sabri S; Ernst J; Plath K
Cell; 2017 Jan; 168(3):442-459.e20. PubMed ID: 28111071
[TBL] [Abstract][Full Text] [Related]
59. Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction.
Lin Z; Perez P; Lei D; Xu J; Gao X; Bao J
Stem Cells; 2011 Dec; 29(12):1963-74. PubMed ID: 21956995
[TBL] [Abstract][Full Text] [Related]
60. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.
Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J
Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
